Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients
Open Access
- 1 April 2021
- journal article
- research article
- Published by Future Medicine Ltd in Future Virology
- Vol. 16 (4), 265-276
- https://doi.org/10.2217/fvl-2020-0304
Abstract
Objective: Researching the prognostic value of myocardial enzymes in COVID-19 patients. Materials & methods: We collected 113 confirmed COVID-19 patients. The dynamic changes of CK, LDH and α-HBDH in patients were studied retrospectively, the correlation between myocardial enzyme index, clinical classification and outcome of patients and its significance to prognosis. Results: There are significant statistical differences between LDH, α-HBDH, CK and the clinical classification, and patient’s outcome. In the receiver operating characteristic curve analysis, LDH, α-HBDH and CK have a good diagnostic value for the death outcome of patients. Conclusion: LDH, α-HBDH and CK were the components of myocardial enzyme profiles, and our results found that they were significantly positively correlated with clinical classification and prognosis of COVID-19 patients. The values of LDH, α-HBDH and CK increased with the increase of the severity of admission clinical classification and the deterioration of outcome. Therefore, we propose that continuous monitoring of LDH, α-HBDH and CK indicators can warn the deterioration of COVID-19 to a certain extent, regardless of whether patients with cardiovascular diseases are combined or not, and prompt early intervention.Keywords
This publication has 19 references indexed in Scilit:
- The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active MetabolismEndocrine, Metabolic & Immune Disorders - Drug Targets, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Analysis of Epidemiological and Clinical Features in Older Patients With Coronavirus Disease 2019 (COVID-19) Outside WuhanClinical Infectious Diseases, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, ChinaClinical Infectious Diseases, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injuryInternational Immunopharmacology, 2019
- Creatine kinase myocardial band - a biomarker to assess prognostically relevant periprocedural myocardial infarctionInternational Journal of Cardiology, 2018